Organization: Health Canada
Year: 2023
Month: April
Request Number: A-2022-001653
Request Summary: Correspondence relating to any abbreviated new drug submission (ANDS) filed since December 1, 2022 where the dosage strength is 10 µg desmopressin in intranasal dosage form.
Disposition: No records exist
Number of pages: 0